ALGS Aligos Therapeutics, Inc. - Common stock
$6,50
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 6, 2026
Rango 52S
$4–$14
26% of range
Calificación del Analista
BUY
14 analysts
Precio Objetivo
$56
+766% upside
P/E (TTM)
-2.7
ROE
-31.1%
Margen de Beneficio Neto
-1106.7%
ALGS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$6.50
Capitalización Bursátil
$40M
P/E (TTM)
-2.7
BPA (TTM)
$-2.45
Ingresos (TTM)
$2M
Rendimiento div.
—
ROE
-31.1%
Deuda/Capital
—
Rango 52S
$4 – $14
ALGS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$2M
2020-12-31
→
2025-12-31
BPA
$-2.45
2022-12-31
→
2025-12-31
Flujo de caja libre
—
2020-12-31
→
2024-12-31
Márgenes
-1106.7%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ALGS
Mediana de Pares
P/E (TTM)
-2.7
0.8
P/S (TTM) (P/V (TTM))
18.4
6.2
P/B (P/C)
0.8
3.0
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ALGS
Mediana de Pares
Operating Margin (Margen Operativo)
-4024.9%
—
Net Profit Margin (Margen de Beneficio Neto)
-1106.7%
-1056.6%
ROA
-30.5%
-118.6%
ROE
-31.1%
-139.5%
ROIC
-166.5%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ALGS
Mediana de Pares
Current Ratio (Ratio corriente)
3.9
2.1
Quick Ratio (Ratio Rápido)
3.7
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ALGS
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-39.5%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ALGS
Mediana de Pares
ALGS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
14 analistas
- Compra fuerte 3 21,4%
- Compra 10 71,4%
- Mantener 1 7,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
7 analistas · 2026-08-14
Mediana
$45.00
← Por Debajo de Todos los Objetivos
$6.50
Mín
$20.00
Máx
$175.00
Objetivo mediano
$45.00
+592,2%
Objetivo medio
$56.29
+765,8%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.25%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.14 | $-1.09 | 0.95% |
| 31 de marzo de 2026 | $-2.21 | $-2.27 | 0.06% |
| 31 de diciembre de 2025 | $-1.91 | $-1.89 | -0.02% |
| 30 de septiembre de 2025 | $-3.04 | $-1.94 | -1.1% |
| 30 de junio de 2025 | $-1.53 | $-2.41 | 0.88% |
| 31 de marzo de 2025 | $-2.11 | $-2.85 | 0.74% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ALGS | $58M | -3.8 | -39.5% | -1106.7% | -31.1% | — |
| MCRB | $142M | 23.2 | — | 721.9% | 14.8% | — |
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | — |
| TVGN | — | — | — | — | — | — |
| ELUT | — | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| CRVO | $73M | — | -58.9% | -673.1% | -104.4% | — |
| QNCX | $187M | -2.0 | — | — | 700.5% | — |
| NXTC | $50M | -0.7 | — | — | -172.9% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $2M | $4M | $6M | $0 | $0 | $0 | |
| R&D Expense | $69M | $70M | $73M | $85M | $104M | $80M | |
| SG&A Expense | $21M | $23M | $31M | $26M | $29M | $18M | |
| Operating Expenses | $90M | $93M | $104M | $111M | $133M | $98M | |
| Operating Income | $-88M | $-89M | $-88M | $-98M | $-128M | $-98M | |
| Pretax Income | $-24M | $-131M | $-87M | $-96M | $-128M | $-108M | |
| Income Tax | $314.0K | $331.0K | $795.0K | $106.0K | $143.0K | $161.0K | |
| Net Income | $-24M | $-131M | $-88M | $-96M | $-128M | $-109M | |
| EPS (Basic) | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · | · | |
| EPS (Diluted) | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · | · | |
| Shares (Basic) | 9,884,955 | 6,264,612 | 2,563,470 | 42,695,227 | · | · | |
| Shares (Diluted) | 9,884,955 | 6,264,612 | 2,563,470 | 42,695,227 | · | · | |
| EBITDA | $-88M | $-89M | $-88M | $-98M | $-128M | $-98M |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $37M | $136M | $81M | $187M | $220M | |
| Short-term Investments | $60M | $20M | · | $44M | $4M | $23M | |
| Other Current Assets | $5M | $5M | $5M | $8M | $14M | $6M | |
| Current Assets | $83M | $62M | $141M | $134M | $204M | $250M | |
| PP&E (Net) | $2M | $2M | $3M | $5M | $6M | $8M | |
| PP&E (Gross) | $15M | $14M | $14M | $14M | $13M | $12M | |
| Accum. Depreciation | $13M | $12M | $11M | $10M | $7M | $4M | |
| Other Non-current Assets | $715.0K | $627.0K | $625.0K | $634.0K | $866.0K | $377.0K | |
| Total Assets | $89M | $70M | $152M | $147M | $235M | $265M | |
| Accounts Payable | $4M | $3M | $3M | $5M | $3M | $3M | |
| Accrued Liabilities | $14M | $16M | $17M | $16M | $25M | $17M | |
| Current Liabilities | $21M | $22M | $24M | $33M | $39M | $30M | |
| Capital Leases | $2M | $5M | $8M | $9M | $11M | $10M | |
| Other Non-current Liabilities | · | · | · | · | $133.0K | $379.0K | |
| Total Liabilities | $35M | $99M | $59M | $43M | $51M | $45M | |
| Common Stock | $9.0K | $8.0K | $7.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-642M | $-618M | $-487M | $-399M | $-303M | $-175M | |
| AOCI | $468.0K | $451.0K | $545.0K | $401.0K | $452.0K | $-188.0K | |
| Stockholders' Equity | $54M | $-29M | $92M | $104M | $185M | $220M | |
| Liabilities + Equity | $89M | $70M | $152M | $147M | $235M | $265M | |
| Shares Outstanding | 6,178,230 | 3,864,436 | 3,003,855 | 42,922,980 | 42,690,229 | 38,120,606 |
Flujo de Efectivo 9
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $8M | $13M | $15M | $13M | $3M | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-83M | $-81M | $-79M | $-79M | $-116M | $-74M | |
| CapEx | · | $130.0K | $19.0K | $943.0K | $892.0K | $2M | |
| Investing Cash Flow | $-38M | $-18M | $45M | $-26M | $3M | $33M | |
| Stock Issued | · | · | $23.0K | · | · | · | |
| Financing Cash Flow | $102M | $355.0K | $88M | $164.0K | $79M | $192M | |
| Taxes Paid | $315.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-81M | $-79M | $-80M | $-117M | $-76M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -4024.9% | -2469.0% | -1423.5% | · | · | · | |
| Net Margin | -1106.7% | -3633.7% | -1416.2% | · | · | · | |
| Pretax Margin | -1092.4% | -3624.5% | -1403.4% | · | · | · | |
| EBITDA Margin | -4024.9% | -2469.0% | -1423.5% | · | · | · | |
| ROA | -30.5% | -118.4% | -58.8% | -50.3% | -51.3% | -52.7% | |
| ROE | -31.1% | -1242.4% | -119.4% | -85.0% | -63.9% | -260.4% | |
| ROIC | -166.5% | 308.5% | -96.6% | -94.0% | -69.5% | -44.5% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 2.9 | 5.9 | 4.0 | 5.2 | 8.3 | |
| Quick Ratio | 3.7 | 2.6 | 5.7 | 3.8 | 4.9 | 8.0 |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -39.5% | -41.7% | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $4M | $6M | $0 | $0 | $0 | |
| Net Income TTM | $-24M | $-131M | $-88M | $-96M | $-128M | $-109M | |
| Market Cap | $58M | $154M | $1.25B | $1.02B | $12.67B | $25.30B | |
| P/E | -3.8 | -1.9 | -0.5 | -10.6 | · | · | |
| P/S | 26.3 | 42.6 | 201.4 | · | · | · | |
| P/B | 1.1 | -5.3 | 13.5 | 9.8 | 68.6 | 115.0 | |
| P / Tangible Book | 1.1 | · | 13.5 | 9.8 | 68.6 | 115.0 | |
| P / Cash Flow | -0.7 | -1.9 | -15.8 | -12.9 | -109.5 | -340.7 | |
| P / FCF | · | -1.9 | -15.8 | -12.7 | -108.7 | -331.5 | |
| Earnings Yield | -26.3% | -52.6% | -206.0% | -9.4% | · | · |
Estado de resultados 13
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $3M | $169.0K | $741.0K | $965.0K | $311.0K | $606.0K | $1M | $1M | $694.0K | $672.0K | $1M | $4M | $140.0K | · | $0 | |
| R&D Expense | $24M | $23M | $17M | $24M | $14M | $15M | $16M | $17M | $21M | $16M | $22M | $16M | $17M | $18M | $19M | $18M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $6M | $5M | $5M | $5M | $6M | $7M | $6M | $6M | $9M | $9M | $7M | $5M | |
| Operating Expenses | $30M | $30M | $22M | $29M | $20M | $20M | $21M | $21M | $27M | $23M | $29M | $22M | $26M | $27M | $26M | $23M | |
| Operating Income | $-2M | $-27M | $-22M | $-28M | $-19M | $-19M | $-21M | $-20M | $-26M | $-22M | $-26M | $-19M | $-19M | $-24M | $-23M | $-19M | |
| Pretax Income | $1M | $-23M | $-20M | $-31M | $-16M | $43M | $-82M | $-19M | $5M | $-35M | $-28M | $-18M | $-18M | $-23M | $-22M | $-19M | |
| Income Tax | $3M | $317.0K | $30.0K | $56.0K | $185.0K | $43.0K | $27.0K | $91.0K | $189.0K | $24.0K | $-30.0K | $29.0K | $757.0K | $39.0K | $49.0K | $-43.0K | |
| Net Income | $-2M | $-23M | $-20M | $-32M | $-16M | $43M | $-82M | $-19M | $5M | $-35M | $-28M | $-18M | $-19M | $-23M | $-22M | $-19M | |
| EPS (Basic) | $-0.14 | $-2.21 | $-3.00 | $-3.04 | $-1.53 | $5.12 | $-13.10 | $-3.07 | $0.81 | $-5.58 | $-22.87 | $-10.37 | $-0.43 | $-0.53 | $-0.50 | $-0.44 | |
| EPS (Diluted) | $-0.14 | $-2.21 | $4.23 | $-3.04 | $-1.53 | $-2.11 | $-13.10 | $-3.07 | $0.81 | $-5.58 | $-22.87 | $-10.37 | $-0.43 | $-0.53 | $-0.50 | $-0.44 | |
| Shares (Basic) | 10,430,808 | 10,402,967 | -19,244,181 | 10,369,535 | 10,351,120 | 8,408,481 | -12,511,505 | 6,272,291 | 6,257,713 | 6,246,113 | -85,301,920 | 1,739,847 | 43,215,478 | 42,910,065 | -85,243,858 | 42,761,928 | |
| Shares (Diluted) | 10,430,808 | 10,402,967 | -19,545,393 | 10,369,535 | 10,351,120 | 8,709,693 | -12,519,645 | 6,272,291 | 6,265,853 | 6,246,113 | -85,301,920 | 1,739,847 | 43,215,478 | 42,910,065 | -85,243,858 | 42,761,928 | |
| EBITDA | $-2M | $-27M | · | $-28M | $-19M | $-19M | · | $-20M | $-26M | $-22M | · | $-19M | $-19M | $-24M | · | $-19M |
Balance general 22
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $30M | $18M | $42M | $19M | $74M | $37M | $35M | $45M | $24M | $136M | $70M | $91M | $79M | $81M | $86M | |
| Short-term Investments | $0 | $25M | $60M | $57M | $104M | $64M | $20M | $40M | $49M | $89M | · | · | $10.0K | $25M | $44M | $56M | |
| Receivables | $28M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $4M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | $6M | $8M | $8M | |
| Current Assets | $62M | $60M | $83M | $103M | $128M | $143M | $62M | $80M | $100M | $118M | $141M | $75M | $94M | $109M | $134M | $150M | |
| PP&E (Net) | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | |
| PP&E (Gross) | $15M | $15M | $15M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | |
| Accum. Depreciation | $13M | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $11M | $11M | $11M | $11M | $10M | $10M | $10M | $9M | |
| Other Non-current Assets | $759.0K | $759.0K | $715.0K | $713.0K | $640.0K | $632.0K | $627.0K | $635.0K | $631.0K | $625.0K | $625.0K | $623.0K | $624.0K | $632.0K | $634.0K | $653.0K | |
| Total Assets | $66M | $65M | $89M | $110M | $135M | $151M | $70M | $88M | $109M | $128M | $152M | $86M | $106M | $122M | $147M | $164M | |
| Accounts Payable | $6M | $8M | $4M | $5M | $4M | $4M | $3M | $3M | $7M | $3M | $3M | $3M | $3M | $3M | $5M | $3M | |
| Accrued Liabilities | $19M | $12M | $14M | $14M | $12M | $11M | $16M | $14M | $12M | $12M | $17M | $12M | $14M | $15M | $16M | $14M | |
| Current Liabilities | $28M | $23M | $21M | $22M | $20M | $19M | $22M | $21M | $24M | $19M | $24M | $22M | $27M | $28M | $33M | $31M | |
| Capital Leases | $288.0K | $659.0K | $2M | $2M | $3M | $4M | $5M | $6M | $6M | $7M | $8M | $8M | $9M | $9M | $9M | $10M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $133.0K | |
| Total Liabilities | $34M | $33M | $35M | $38M | $33M | $34M | $99M | $38M | $42M | $68M | $59M | $31M | $36M | $37M | $43M | $42M | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $4.0K | $0 | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-667M | $-665M | $-642M | $-622M | $-591M | $-575M | $-618M | $-536M | $-517M | $-522M | $-487M | $-459M | $-441M | $-422M | $-399M | $-377M | |
| AOCI | $437.0K | $438.0K | $468.0K | $455.0K | $420.0K | $447.0K | $451.0K | $577.0K | $494.0K | $476.0K | $545.0K | $497.0K | $497.0K | $499.0K | $401.0K | $159.0K | |
| Stockholders' Equity | $32M | $32M | $54M | $72M | $102M | $116M | $-29M | $50M | $67M | $60M | $92M | $55M | $70M | $85M | $104M | $122M | |
| Liabilities + Equity | $66M | $65M | $89M | $110M | $135M | $151M | $70M | $88M | $109M | $128M | $152M | $86M | $106M | $122M | $147M | $164M | |
| Shares Outstanding | 6,236,828 | 6,188,186 | 6,178,230 | 6,153,507 | 6,151,274 | 6,114,801 | 3,864,436 | 3,324,780 | 79,785,898 | 75,668,521 | 3,003,855 | 43,502,582 | 43,502,582 | 42,940,089 | 42,922,980 | 42,815,593 |
Flujo de Efectivo 6
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $1M | $959.0K | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | |
| Operating Cash Flow | $-25M | $-23M | $-22M | $-24M | $-16M | $-21M | $-18M | $-20M | $-19M | $-23M | $-23M | $-20M | $-14M | $-22M | $-17M | $-17M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | $7.0K | $91.0K | $3.0K | |
| Investing Cash Flow | $25M | $35M | $-2M | $48M | $-39M | $-44M | $20M | $10M | $40M | $-89M | $-7.0K | $-9.0K | $25M | $20M | $12M | $32M | |
| Financing Cash Flow | $220.0K | $-62.0K | $123.0K | $-53.0K | $-177.0K | $102M | $97.0K | $-4.0K | $281.0K | $-19.0K | $88M | $-21.0K | $414.0K | $-1.0K | $121.0K | $-19.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-22M | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -951.5% | · | -3827.4% | -1924.0% | -6187.5% | · | -1610.5% | -2489.5% | -3176.7% | · | -1757.7% | -445.8% | -17084.3% | · | · | |
| Net Margin | · | -814.1% | · | -4256.0% | -1643.8% | 13854.7% | · | -1540.7% | 477.0% | -5023.5% | · | -1662.8% | -437.6% | -16396.4% | · | · | |
| Pretax Margin | · | -802.9% | · | -4248.4% | -1624.7% | 13868.5% | · | -1533.4% | 494.8% | -5020.0% | · | -1660.1% | -420.0% | -16368.6% | · | · | |
| EBITDA Margin | · | -951.5% | · | -3827.4% | -1924.0% | -6187.5% | · | -1610.5% | -2489.5% | -3176.7% | · | -1757.7% | -445.8% | -17084.3% | · | · | |
| ROA | -1.5% | -21.4% | · | -31.8% | -13.0% | 30.9% | · | -22.1% | 4.7% | -27.9% | · | -14.4% | -13.0% | -13.8% | · | -8.7% | |
| ROE | -2.2% | -31.1% | · | -51.7% | -18.8% | 48.9% | · | -36.7% | 7.4% | -48.2% | · | -20.4% | -18.2% | -19.3% | · | -11.0% | |
| ROIC | 6.8% | -85.9% | · | -39.6% | -18.4% | -16.5% | · | -40.4% | -37.9% | -36.9% | · | -34.8% | -28.6% | -28.3% | · | -15.5% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 2.6 | · | 4.7 | 6.3 | 7.6 | · | 3.8 | 4.2 | 6.3 | · | 3.3 | 3.5 | 3.9 | · | 4.9 | |
| Quick Ratio | 2.1 | 2.4 | · | 4.5 | 6.1 | 7.3 | · | 3.6 | 4.0 | 6.0 | · | 3.1 | 3.3 | 3.7 | · | 4.7 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $5M | · | $3M | $4M | $3M | · | $4M | $7M | $6M | · | $6M | $4M | · | · | · | |
| Net Income TTM | $-72M | $-27M | · | $-24M | $13M | $-6M | · | $-67M | $-67M | $-95M | · | $-78M | $-80M | $-97M | · | $-107M | |
| Market Cap | $36M | $46M | · | $60M | $44M | $50M | · | $29M | $698M | $1.85B | · | $812M | $1.06B | $938M | · | $1.18B | |
| P/E | -0.8 | -0.8 | · | -1.0 | -1.2 | -0.8 | · | -0.5 | -0.6 | -1.4 | · | -1.6 | -13.0 | -9.6 | · | -10.9 | |
| P/S | 7.9 | 9.5 | · | 18.5 | 12.4 | 15.2 | · | 7.0 | 97.9 | 298.4 | · | 147.2 | 238.2 | · | · | · | |
| P/B | 1.1 | 1.4 | · | 0.8 | 0.4 | 0.4 | · | 0.6 | 10.4 | 31.0 | · | 14.8 | 15.2 | 11.1 | · | 9.7 | |
| P / Tangible Book | 1.1 | 1.4 | · | 0.8 | 0.4 | 0.4 | · | 0.6 | 10.4 | 31.0 | · | 14.8 | 15.2 | 11.1 | · | 9.7 | |
| P / Cash Flow | · | -2.0 | · | · | · | -2.4 | · | · | · | -81.5 | · | · | · | -41.9 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -41.9 | · | · | |
| Earnings Yield | -119.9% | -119.6% | · | -99.5% | -81.8% | -120.6% | · | -210.3% | -177.9% | -69.0% | · | -63.0% | -7.7% | -10.4% | · | -9.2% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $2M | $4M | $6M | $0 | $0 |
| Margen Operativo % | -4024.9% | -2469.0% | -1423.5% | — | — |
| Beneficio neto | $-24M | $-131M | $-88M | $-96M | $-128M |
| EPS Diluido | $-2.45 | $-20.94 | $-34.20 | $-2.25 | — |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 3.9 | 2.9 | 5.9 | 4.0 | 5.2 |
| Ratio Rápido | 3.7 | 2.6 | 5.7 | 3.8 | 4.9 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | — | $-81M | $-79M | $-80M | $-117M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 35 declarantes · $14.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 7 (+3 vs trimestre anterior) | 8 (+1 vs trimestre anterior) | 5 (-3 vs trimestre anterior) | 5 (-2 vs trimestre anterior) | -318K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Deep Track Capital, LP | $2 562 515 | 444 110 | 17,49% | Acciones |
| Alyeska Investment Group, L.P. | $2 377 240 | 412 000 | 16,23% | Acciones |
| Sio Capital Management, LLC | $1 888 157 | 327 237 | 12,89% | Acciones |
| VANGUARD GROUP INC | $1 593 925 | 171 022 | 10,88% | Acciones |
| MARSHALL WACE, LLP | $1 422 761 | 246 579 | 9,71% | Acciones |
| Woodline Partners LP | $1 023 379 | 177 362 | 6,99% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 012 883 | 175 543 | 6,91% | Acciones |
| BAKER BROS. ADVISORS LP | $479 227 | 83 055 | 3,27% | Acciones |
| HHLR ADVISORS, LTD. | $439 945 | 76 247 | 3,00% | Acciones |
| UBS Group AG | $302 925 | 52 500 | 2,07% | Acciones |
| D. E. Shaw & Co., Inc. | $253 851 | 43 995 | 1,73% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $217 078 | 37 599 | 1,48% | Acciones |
| JANE STREET GROUP, LLC | $168 426 | 29 190 | 1,15% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $165 091 | 28 612 | 1,13% | Acciones |
| AlphaQuest LLC | $129 324 | 13 876 | 0,88% | Acciones |
| TWO SIGMA ADVISERS, LP | $121 160 | 13 000 | 0,83% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $114 298 | 19 809 | 0,78% | Acciones |
| Verition Fund Management LLC | $108 978 | 18 887 | 0,74% | Acciones |
| Trexquant Investment LP | $71 196 | 12 339 | 0,49% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $62 316 | 10 800 | 0,43% | Acciones |
| Rockefeller Capital Management L.P. | $57 700 | 10 000 | 0,39% | Acciones |
| Federation des caisses Desjardins du Quebec | $26 831 | 4 650 | 0,18% | Acciones |
| Golden State Wealth Management, LLC | $15 429 | 2 674 | 0,11% | Acciones |
| ROYAL BANK OF CANADA | $12 000 | 2 125 | 0,08% | Acciones |
| CITIGROUP INC | $10 432 | 1 808 | 0,07% | Acciones |
| BlackRock, Inc. | $6 289 | 1 090 | 0,04% | Acciones |
| Tower Research Capital LLC (TRC) | $2 071 | 359 | 0,01% | Acciones |
| JPMORGAN CHASE & CO | $1 727 | 318 | 0,01% | Acciones |
| MORGAN STANLEY | $877 | 152 | 0,01% | Acciones |
| SBI Securities Co., Ltd. | $727 | 126 | 0,00% | Acciones |
| WELLS FARGO & COMPANY/MN | $577 | 100 | 0,00% | Acciones |
| FMR LLC | $58 | 10 | 0,00% | Acciones |
| AlphaMark Advisors, LLC | $44 | 1 100 | 0,00% | Acciones |
| ELEVATION WEALTH PARTNERS, LLC | $24 | 4 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $17 | 3 | 0,00% | Acciones |
Informantes de la empresa 9 insiders · 0 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Margarita Chavez | Consejero | 25 de junio de 2026 A | — | 0 | 0 | $0 |
| Peter Hirth | Consejero | 25 de junio de 2026 A | — | 0 | 0 | $0 |
| Carole Nuechterlein | Consejero | 25 de junio de 2026 A | — | 0 | 0 | $0 |
| Bridget A Martell | Consejero | 25 de junio de 2026 A | — | 0 | 0 | $0 |
| Heather Preston | Consejero | 25 de junio de 2026 A | — | 0 | 0 | $0 |
| James Paul Scopa | Consejero | 25 de junio de 2026 A | — | 0 | 0 | $0 |
| Thomas Woiwode | Consejero | 11 de junio de 2021 J | 4 452 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Propietario del 10% | 20 de octubre de 2020 C | 1 906 191 | 0 | 0 | $0 |
| Novo Holdings A/S | Propietario del 10% | 20 de octubre de 2020 C | 2 614 563 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Lawrence M. Blatt ×2 presentaciones | 24 de junio de 2026 | 5,60% | Presentación inicial | — | SEC |
| Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC ×4 presentaciones | 8 de febrero de 2024 | — | Presentación inicial | — | SEC |
| Lawrence M. Blatt, Ph.D. | 6 de noviembre de 2023 | — | Presentación inicial | — | SEC |
| Novo Holdings A/S ×3 presentaciones | 31 de enero de 2022 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 5 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 16 428 SH | 8 de agosto de 2026 | Diario |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1 427 NS | 31 de mayo de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1 172 NS | 30 de abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 46 773 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 128 770 SH | 8 de agosto de 2026 | Diario |